Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

GenEdit

Main focus: Next-generation delivery systems

Company stage: Pre-clinical

Diseases (gene editing): Undisclosed

Genome editing tool: CRISPR

Funding stage: Private

Location: San Francisco, CA, USA

Website: https://genedit.com/

Gene editing partnerships: Sarepta Therapeutics

GenEdit develops next-generation in vivo gene delivery systems. The company raised $26M in a Series A funding round in September 2021. The technology is based on non-lipid polymer nanoparticles, and the company yet has to disclose its leading pre-clinical programmes.

Tags

HashtagGenEdit

Company: GenEdit
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine